Bladder cancer is a prevalent and highly recurrent malignancy within the urinary tract. The accurate segmentation of the bladder wall and tumor in magnetic resonance imaging (MRI) is a crucial step in distinguishing between non-muscle-invasive and muscle-invasive types of bladder cancer, which plays a pivotal role in guiding clinical treatment decisions and influencing postoperative quality of life. The performance of data-driven methods is highly dependent on the quality of the annotations and datasets, however the amount of high-quality annotated data is very limited given the difficulty of professional radiologists to distinguish the mixed regions between the bladder wall and the tumor. The performance of the data-driven approach is highly dependent on the quality of the annotation and datasets, Therefore, in order to alleviate these problems and take full advantage of the potential of limited annotated and unlabeled data, we designed a semi-supervised multi-region framework for bladder wall and tumor segmentation. Our framework incorporates wall-enhanced self-supervised pre-training, designed to enhance discrimination of the bladder wall, and a semi-supervised segmentation network that utilizes both limited high-quality annotated data and unlabeled data. Contrast consistency and reconstruction observation losses are introduced to constrain the model to enhance the bladder walls, and adaptive learning rate and post-processing techniques are implemented to further improve segmentation performance. Extensive experimental validation demonstrated that our proposed method achieves promising results in the segmentation of both the bladder wall and the tumor. The average Dice Similarity Coefficients (DSCs) of the proposed method for the bladder wall and tumor were 0.8351 and 0.9175, respectively. Visualization results indicated that our method can effectively reduce excessive segmentation artifacts outside the bladder, and improve the clinical significance of the segmentation results.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11672963 | PMC |
http://dx.doi.org/10.3390/bioengineering11121225 | DOI Listing |
Acta Endocrinol (Buchar)
January 2025
All India Institute of Medical Science, Department of Pathology & Lab Medicine, Mangalagiri, Guntur, India.
Unlabelled: Urinary Bladder paraganglioma accounts for 0.06% of all bladder tumors and 1% of all pheochromocytoma. Most tumors are localized at the dome or trigone and are unifocal.
View Article and Find Full Text PDFFront Surg
January 2025
Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Objectives: To explore the experience of tumor control technique in robot-assisted laparoscopic bladder diverticulectomy (RALBD) in the treatment of bladder diverticulum tumor, intraoperative tumor control and postoperative comprehensive treatment.
Patients And Methods: We treated three male patients with bladder diverticulum tumors. Case 1 involved a 63-year-old with a 3.
Front Pharmacol
January 2025
Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Background: Radical cystectomy constitutes the standard therapeutic approach for high-risk urothelial carcinomas of the bladder. Contemporary guidelines advise urologists to discontinue anticoagulation therapy during the perioperative period to mitigate the risk of significant intraoperative or postoperative hemorrhage. Nevertheless, in elderly patients with a history of coronary artery disease, the cessation of anticoagulant medication elevates the risk of acute myocardial infarction, thereby posing a substantial threat to their survival.
View Article and Find Full Text PDFBMJ Case Rep
January 2025
Surgical Oncology, Aster Hospitals Inc, Bangalore, Karnataka, India.
Ovarian cancer is the second most fatal gynaecological malignancy. The relapses after treatment of ovarian cancer usually occur within 2 years after completion of the first-line therapy. Recurrent ovarian cancer commonly presents as peritoneal surface deposits in the abdomen with or without ascites.
View Article and Find Full Text PDFBMC Vet Res
January 2025
Faculty of Veterinary Sciences, University of Buenos Aires, Buenos Aires, Argentina.
Background: Lower urinary tract disease is a common clinical condition in dogs, usually presenting with dysuria, pollakiuria and haematuria. Diabetes mellitus is a predisposing factor for urinary tract infection in both humans and dogs and does not necessarily present with clinical signs. In this case report, we describe for the first time a case of cystitis glandularis in a dog with diabetes mellitus, associated with Escherichia coli urinary tract infection.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!